- Home
- MLGO vs ATOS Comparison
MLGO vs ATOS Comparison
Compare MLGO & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLGO
- ATOS
- Stock Information
- Founded
- MLGO 2018
- ATOS 2009
- Country
- MLGO China
- ATOS United States
- Employees
- MLGO N/A
- ATOS N/A
- Industry
- MLGO EDP Services
- ATOS Biotechnology: Pharmaceutical Preparations
- Sector
- MLGO Technology
- ATOS Health Care
- Exchange
- MLGO Nasdaq
- ATOS Nasdaq
- Market Cap
- MLGO 99.2M
- ATOS 107.2M
- IPO Year
- MLGO N/A
- ATOS 2012
- Fundamental
- Price
- MLGO $8.58
- ATOS $0.76
- Analyst Decision
- MLGO
- ATOS Strong Buy
- Analyst Count
- MLGO 0
- ATOS 3
- Target Price
- MLGO N/A
- ATOS $6.17
- AVG Volume (30 Days)
- MLGO 355.3K
- ATOS 551.3K
- Earning Date
- MLGO 09-18-2025
- ATOS 08-12-2025
- Dividend Yield
- MLGO N/A
- ATOS N/A
- EPS Growth
- MLGO N/A
- ATOS N/A
- EPS
- MLGO 16.40
- ATOS N/A
- Revenue
- MLGO $74,185,505.00
- ATOS N/A
- Revenue This Year
- MLGO N/A
- ATOS N/A
- Revenue Next Year
- MLGO N/A
- ATOS N/A
- P/E Ratio
- MLGO $0.53
- ATOS N/A
- Revenue Growth
- MLGO N/A
- ATOS N/A
- 52 Week Low
- MLGO $8.13
- ATOS $0.55
- 52 Week High
- MLGO $972.00
- ATOS $1.66
- Technical
- Relative Strength Index (RSI)
- MLGO 36.51
- ATOS 45.49
- Support Level
- MLGO $8.63
- ATOS $0.81
- Resistance Level
- MLGO $9.46
- ATOS $0.78
- Average True Range (ATR)
- MLGO 0.59
- ATOS 0.03
- MACD
- MLGO 0.63
- ATOS 0.00
- Stochastic Oscillator
- MLGO 31.31
- ATOS 50.71
About MLGO MicroAlgo Inc.
MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.